Global Endometriosis Treatment Market Size study, By Drug Type {Oral ContraceptivesProgestins, NSAIDs, GnRH Analogues, LNR-IUDs, Others}, By Treatment Type {Hormonal Therapy, Pain Management}, By End-use{Hospital Pharmacies, Retail Pharmacies, Drug stores, e-Commerce}, Analysis Regional Forecasts 2021-2027
- BIZ4621833
- 200 Pages
- August 2021
- Pharmaceuticals
The global Endometriosis Treatment Market reached USD XXX Billion in 2020. The Global Endometriosis Treatment Market tends to grow by a CAGR of XX% in the 2021-2027 period. When tissues that make up the lining of the uterus, grow outside of it, the disorder is called endometriosis. In Endometriosis, women face pain in the lower abdomen, cramps, and sometimes a high flow of blood. Endometriosis is divided into stages between level 1 (minimum or starting stage) to level 4 (severe or extreme stage). The established player has odds in their favor to lead the market and also expand their business portfolio by launching higher efficient and well-tested drugs into the market. One of the major trends that are driving this market is the awareness among women health and safety and governments investing into better treatment facilities and upgraded technologies used to reduce these diseases. Patient assistance programs are also spreading widely among various regions. However, limited availability of diagnostics is a major factor affecting this market negatively, but diagnostic facilities are expected to increase in the future. The ultrasound market is going to cover the largest market share, due to the upgradation in the technology and growing demand for diagnostic procedures. In 2018, Astellas Pharma announced the manufacturing of Opigolix drug that will be used for oral treatment of endometriosis. The key regions covered in the global Endometriosis Treatment market are North America, Latin America, Europe, East Asia, South Asia-Pacific, and the Middle East & Africa. North America holds the largest market share, because of growing awareness about endometriosis treatment and the rate of incidences growing rapidly in that region. Due to higher population, growing market, and a large number of market players being present in the market, the Asia Pacific region is expected to grow in the future. Major market players included in this report are: Abbott Laboratories AbbVie Inc. Astellas Pharma Inc. AstraZeneca PLC Bayer AG Eli Lilly and Company Ipsen Meditrina Pharmaceuticals Private Limited Myovant Sciences Ltd Neurocrine Biosciences Inc. The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below: By Drug Type: Oral Contraceptives Progestins NSAIDs GnRH Analogues LNR-IUDs Others By Treatment Type: Hormonal Therapy Pain Management By End-use: Hospital Pharmacies Retail Pharmacies Drugstores e-Commerce By Region: North America The U.S. Canada Europe UK Germany France Spain Italy ROE Asia Pacific China India Japan Australia South Korea RoAPAC Latin America Brazil Mexico Rest of the World Furthermore, the years considered for the study are as follows: Historical year – 2018, 2019 Base year – 2020 Forecast period – 2021 to 2027 Target Audience of the Global Endometriosis Treatment Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture capitalists Value-Added Resellers (VARs) Third-party knowledge providers Investment bankers Investors
Chapter 1. Executive Summary 1.1. Market Snapshot 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion) 1.2.1. Oxytocic Pharmaceuticals Market, by Drug Type, 2019-2027 (USD Billion) 1.2.2. Oxytocic Pharmaceuticals Market, by Treatment Type, 2019-2027 (USD Billion) 1.2.3. Oxytocic Pharmaceuticals Market, by End-use, 2019-2027 (USD Billion) 1.2.4. Global Oxytocic Pharmaceuticals Market, by region, 2019-2027 (USD Billion) 1.3. Key Trends 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Global Oxytocic Pharmaceuticals Market Definition and Scope 2.1. The objective of the Study 2.2. Market Definition & Scope 2.2.1. Scope of the Study 2.2.2. Industry Evolution 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Global Oxytocic Pharmaceuticals Market Dynamics 3.1. Global Oxytocic Pharmaceuticals Market Impact Analysis (2019-2027) 3.1.1. Market Drivers 3.1.1.1. Growing awareness about women health and safety 3.1.1.2. The surge in demand for patient assistance program 3.1.2. Market Challenges 3.1.2.1. Limited availability of diagnostics 3.1.3. Market Opportunities 3.1.3.1. Vertical business development (product expansions) Chapter 4. Global Oxytocic Pharmaceuticals Market Industry Analysis 4.1. Porter’s 5 Force Model 4.1.1. Bargaining Power of Suppliers 4.1.2. Bargaining Power of Buyers 4.1.3. The threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027) 4.2. PEST Analysis 4.2.1. Political 4.2.2. Economical 4.2.3. Social 4.2.4. Technological 4.3. Investment Adoption Model 4.4. Analyst Recommendation & Conclusion Chapter 5. Global Oxytocic Pharmaceuticals Market by Drug Type 5.1. Market Snapshot 5.2. Global Oxytocic Pharmaceuticals Market by Drug Type, Performance - Potential Analysis 5.3. Global Oxytocic Pharmaceuticals Market estimates & Forecasts by Drug Type 2018-2027 (USD Billion) 5.4. Oxytocic Pharmaceuticals Market, Sub Segment Analysis 5.4.1. Oral Contraceptives 5.4.2. Progestins 5.4.3. NSAIDs 5.4.4. GnRH Analogues 5.4.5. LNR-IUDs 5.4.6. Others Chapter 6. Global Oxytocic Pharmaceuticals Market by Treatment Type 6.1. Market Snapshot 6.2. Global Oxytocic Pharmaceuticals Market by Treatment Type, Performance - Potential Analysis 6.3. Global Oxytocic Pharmaceuticals Market estimates & Forecasts by Treatment Type 2018-2027 (USD Billion) 6.4. Oxytocic Pharmaceuticals Market, Sub Segment Analysis 6.4.1. Hormonal Therapy 6.4.2. Pain Management Chapter 7. Global Oxytocic Pharmaceuticals Market by End-use 7.1. Market Snapshot 7.2. Global Oxytocic Pharmaceuticals Market by End-use, Performance - Potential Analysis 7.3. Global Oxytocic Pharmaceuticals Market estimates & Forecasts by End-use 2018-2027 (USD Billion) 7.4. Oxytocic Pharmaceuticals Market, Sub Segment Analysis 7.4.1. Hospital Pharmacies 7.4.2. Retail Pharmacies 7.4.3. Drugstores 7.4.4. e-Commerce Chapter 8. Global Oxytocic Pharmaceuticals Market, Regional Analysis 8.1. Global Oxytocic Pharmaceuticals Market, Regional Market Snapshot 8.2. North America Oxytocic Pharmaceuticals Market 8.2.1. U.S. Oxytocic Pharmaceuticals Market 8.2.1.1. Drug Type breakdown estimates & forecasts, 2018-2027 8.2.1.2. Treatment Type breakdown estimates & forecasts, 2018-2027 8.2.1.3. End-use breakdown estimates & forecasts, 2018-2027 8.2.2. Canada Oxytocic Pharmaceuticals Market 8.3. Europe Oxytocic Pharmaceuticals Market Snapshot 8.3.1. The U.K. Oxytocic Pharmaceuticals Market 8.3.2. Germany Oxytocic Pharmaceuticals Market 8.3.3. France Oxytocic Pharmaceuticals Market 8.3.4. Spain Oxytocic Pharmaceuticals Market 8.3.5. Italy Oxytocic Pharmaceuticals Market 8.3.6. Rest of Europe Oxytocic Pharmaceuticals Market 8.4. Asia-Pacific Oxytocic Pharmaceuticals Market Snapshot 8.4.1. China Oxytocic Pharmaceuticals Market 8.4.2. India Oxytocic Pharmaceuticals Market 8.4.3. Japan Oxytocic Pharmaceuticals Market 8.4.4. Australia Oxytocic Pharmaceuticals Market 8.4.5. South Korea Oxytocic Pharmaceuticals Market 8.4.6. Rest of Asia Pacific Oxytocic Pharmaceuticals Market 8.5. Latin America Oxytocic Pharmaceuticals Market Snapshot 8.5.1. Brazil Oxytocic Pharmaceuticals Market 8.5.2. Mexico Oxytocic Pharmaceuticals Market 8.6. Rest of The World Oxytocic Pharmaceuticals Market Chapter 9. Competitive Intelligence 9.1.1. Top Market Strategies 9.2. Company Profiles 9.2.1. Abbott Laboratories 9.2.1.1. Key Information 9.2.1.2. Overview 9.2.1.3. Financial (Subject to Data Availability) 9.2.1.4. Product Summary 9.2.1.5. Recent Developments 9.2.2. AbbVie Inc. 9.2.3. Astellas Pharma Inc. 9.2.4. AstraZeneca PLC 9.2.5. Bayer AG 9.2.6. Eli Lilly and Company 9.2.7. Ipsen 9.2.8. Meditrina Pharmaceuticals Private Limited 9.2.9. Myovant Sciences Ltd 9.2.10. Neurocrine Biosciences Inc. Chapter 10. Research Process 10.1. Research Process 10.1.1. Data Mining 10.1.2. Analysis 10.1.3. Market Estimation 10.1.4. Validation 10.1.5. Publishing 10.2. Research Attributes 10.3. Research Assumption
List of Tables TABLE 1. Global Oxytocic Pharmaceuticals Market, report scope TABLE 2. Global Oxytocic Pharmaceuticals Market estimates & forecasts by region 2018-2027 (USD Billion) TABLE 3. Global Oxytocic Pharmaceuticals Market estimates & forecasts by Drug Type 2018-2027 (USD Billion) TABLE 4. Global Oxytocic Pharmaceuticals Market estimates & forecasts by Treatment Type 2018-2027 (USD Billion) TABLE 5. Global Oxytocic Pharmaceuticals Market estimates & forecasts by End-use 2018-2027 (USD Billion) TABLE 6. Global Oxytocic Pharmaceuticals Market by segment, estimates & forecasts, 2018-2027 (USD Billion) TABLE 7. Global Oxytocic Pharmaceuticals Market by region, estimates & forecasts, 2018-2027 (USD Billion) TABLE 8. Global Oxytocic Pharmaceuticals Market by segment, estimates & forecasts, 2018-2027 (USD Billion) TABLE 9. Global Oxytocic Pharmaceuticals Market by region, estimates & forecasts, 2018-2027 (USD Billion) TABLE 10. Global Oxytocic Pharmaceuticals Market by segment, estimates & forecasts, 2018-2027 (USD Billion) TABLE 11. Global Oxytocic Pharmaceuticals Market by region, estimates & forecasts, 2018-2027 (USD Billion) TABLE 12. Global Oxytocic Pharmaceuticals Market by segment, estimates & forecasts, 2018-2027 (USD Billion) TABLE 13. Global Oxytocic Pharmaceuticals Market by region, estimates & forecasts, 2018-2027 (USD Billion) TABLE 14. Global Oxytocic Pharmaceuticals Market by segment, estimates & forecasts, 2018-2027 (USD Billion) TABLE 15. Global Oxytocic Pharmaceuticals Market by region, estimates & forecasts, 2018-2027 (USD Billion) TABLE 16. U.S. Oxytocic Pharmaceuticals Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 17. U.S. Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 18. U.S. Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 19. Canada Oxytocic Pharmaceuticals Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 20. Canada Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 21. Canada Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 22. UK Oxytocic Pharmaceuticals Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 23. UK Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 24. UK Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 25. Germany Oxytocic Pharmaceuticals Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 26. Germany Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 27. Germany Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 28. RoE Oxytocic Pharmaceuticals Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 29. RoE Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 30. RoE Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 31. China Oxytocic Pharmaceuticals Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 32. China Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 33. China Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 34. India Oxytocic Pharmaceuticals Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 35. India Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 36. India Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 37. Japan Oxytocic Pharmaceuticals Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 38. Japan Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 39. Japan Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 40. RoAPAC Oxytocic Pharmaceuticals Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 41. RoAPAC Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 42. RoAPAC Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 43. Brazil Oxytocic Pharmaceuticals Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 44. Brazil Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 45. Brazil Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 46. Mexico Oxytocic Pharmaceuticals Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 47. Mexico Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 48. Mexico Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 49. RoLA Oxytocic Pharmaceuticals Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 50. RoLA Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 51. RoLA Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 52. Row Oxytocic Pharmaceuticals Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 53. Row Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 54. Row Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 55. List of secondary sources, used in the study of Oxytocic Pharmaceuticals Market TABLE 56. List of primary sources, used in the study of Oxytocic Pharmaceuticals Market TABLE 57. Years Considered for the study TABLE 58. Exchange rates considered
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
